March 2021. Volume 17. Number 1

Multisystem inflammatory syndrome associated with SARS-CoV-2. An emerging entity?

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Kaushik A, Gupta S, Sood M, Sharma S, Verma S. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection. Pediatr Infect Dis J. 2020.39:e340-e346.

Reviewers: Oltra Benavent M1, Ochoa Sangrador C2.
1Sección de Patología Infecciosa Infantil. Hospital Universitari i Politècnic La Fe. Valencia. España.
2Servicio de Pediatría. Complejo Asistencial de Zamora. Zamora. España.
Correspondence: Manuel Oltra Benavent . Email: oltra.benavent@gmail.com
Reception date: 03/12/2020
Acceptance date: 08/01/2021
Publication date: 13/01/2021

Abstract

Authors’ conclusions: fever, gastrointestinal symptoms and Kawasaki disease like simptoms were the main presenting symptoms of multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection. Although most children required intensive care and immunomodulatory therapies, favorable outcomes were reported in the majority with low-mortality rates.

Reviewers’ commentary: the results of this study describe the usual clinical pattern of patients with multisystem inflammatory syndrome, their care needs and their prognosis, although they do not provide information on the effectiveness of the different treatments used. The implementation of consensus protocols and their evaluation in prospective studies will allow us to establish their effectiveness.

How to cite this article

Oltra Benavent M, Ochoa Sangrador C. Síndrome inflamatorio multisistémico asociado a SARS-CoV-2. ¿Una entidad emergente? Evid Pediatr. 2021;17:3.

AVC | Critically appraised articles

Kaushik A, Gupta S, Sood M, Sharma S, Verma S. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection. Pediatr Infect Dis J. 2020.39:e340-e346.

Reviewers: Oltra Benavent M1, Ochoa Sangrador C2.
1Sección de Patología Infecciosa Infantil. Hospital Universitari i Politècnic La Fe. Valencia. España.
2Servicio de Pediatría. Complejo Asistencial de Zamora. Zamora. España.
Correspondence: Manuel Oltra Benavent . Email: oltra.benavent@gmail.com
Reception date: 03/12/2020
Acceptance date: 08/01/2021
Publication date: 13/01/2021

How to cite this article

Oltra Benavent M, Ochoa Sangrador C. Síndrome inflamatorio multisistémico asociado a SARS-CoV-2. ¿Una entidad emergente? Evid Pediatr. 2021;17:3.

13/01/2021

Linked Comment